(Q34759406)

English

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

phase I clinical trial

0 references

oncolytic virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C L White

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

K R Twigger

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

L Vidal

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

J S De Bono

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

M Coffey

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

L Heinemann

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

R Morgan

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

A Merrick

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

F Errington

9

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

R G Vile

10

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

A A Melcher

11

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

H S Pandha

12

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

K J Harrington

13

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

6 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

911-920

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

https://scigraph.springernature.com/pub.10.1038/gt.2008.21

0 references

Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

21 January 2018

Prevalence of Reovirus‐Specific Antibodies in Young Children in Nashville, Tennessee

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

21 January 2018

The preferential cytotoxicity of reovirus for certain transformed cell lines

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

21 January 2018

Reovirus therapy of tumors with activated Ras pathway

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

21 January 2018

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

21 January 2018

Immune responses to AAV in a phase I study for Canavan disease.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

21 January 2018

Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

21 January 2018

Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

21 January 2018

Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

21 January 2018

Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

21 January 2018

Prevalence of ras gene mutations in human colorectal cancers

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

21 January 2018

High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

7 January 2021

based on heuristic

inferred from DOI database lookup

The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.21

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/GT.2008.21

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34759406&oldid=1970095526"